Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, January 2024

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 39,641 followers.

RT @ProfJohnCrown: Great work!! Well done !!!

RT @SVHGLibrary: Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells. https://t.co/…

Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells. https://t.co/93oLicix1t

RT @coileain: Congrats to the team, Thamir Mahgoub, Emmet Jordan and @Amira_etc, on publication of this pre-clinical study examining ABT-75…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.